ALOPRIM Drug Patent Profile
✉ Email this page to a colleague
When do Aloprim patents expire, and when can generic versions of Aloprim launch?
Aloprim is a drug marketed by Mylan and is included in one NDA.
The generic ingredient in ALOPRIM is allopurinol sodium. There are twenty-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the allopurinol sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Aloprim
A generic version of ALOPRIM was approved as allopurinol sodium by HIKMA on August 26th, 2004.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ALOPRIM?
- What are the global sales for ALOPRIM?
- What is Average Wholesale Price for ALOPRIM?
Summary for ALOPRIM
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 274 |
| Clinical Trials: | 3 |
| Patent Applications: | 5,742 |
| Drug Prices: | Drug price information for ALOPRIM |
| What excipients (inactive ingredients) are in ALOPRIM? | ALOPRIM excipients list |
| DailyMed Link: | ALOPRIM at DailyMed |
Recent Clinical Trials for ALOPRIM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Washington University School of Medicine | Phase 1/Phase 2 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 4 |
| University of California, San Francisco | Phase 4 |
Pharmacology for ALOPRIM
| Drug Class | Xanthine Oxidase Inhibitor |
| Mechanism of Action | Xanthine Oxidase Inhibitors |
US Patents and Regulatory Information for ALOPRIM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan | ALOPRIM | allopurinol sodium | INJECTABLE;INJECTION | 020298-001 | May 17, 1996 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
